Optos reports loss

Article

According to The Financial Times, the retinal imaging company, Optos plc has reported a $4.86 million loss and reduced its headcount by 20%.

According to The Financial Times, the retinal imaging company, Optos plc has reported a $4.86 million loss and reduced its headcount by 20%.

In April last year it launched the P200C which was intended for use in advanced clinical optometry and ophthalmology. Capturing images in the mid to the far periphery of the retina it was potentially able to reach the ora serrata. It planned to market the device on a pay-per-patient basis in the UK, Germany, US and Canada.

The business took an exceptional charge of $4.9 million to cover the costs of refocusing on its core retinal imaging business. CEO, Rod Davis, who was appointed last is reported as saying: "I believe the steps we are taking and the renewed focus on our core optometry business will drive improved business performance in the medium term."

Related Videos
Ramin Tadayoni, MD, speaks with Sheryl Stevenson
Jennifer I. Lim, MD, FARVO, FASRS, Director of Retina Service, University of Illinois at Chicago
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center
Carl D. Regillo, MD, FACS, FASRS, Chief of Retina Service, Wills Eye Hospital, Philadelphia, PA
Arshad Khanani, MD, MA FASRS, on a virtual call
Penny A Asbell, MD, FACS speaks at the 2023 AAO meeting
© 2024 MJH Life Sciences

All rights reserved.